Dr Joseph M Hogan, MD in Philadelphia, PA - Internal Medicine

Dr Joseph M Hogan, MD is a Internal Medicine - Rheumatology physician based in Philadelphia, Pennsylvania. Dr Joseph M Hogan is licensed to practice in Pennsylvania (license number MDOO5859E) and his current practice location is 1726 S Broad St, Philadelphia, Pennsylvania. He can be reached at his office (for appointments etc.) via phone at (215) 334-0700.

NPI number for Dr Joseph M Hogan is 1861653495 and his current mailing address is 1726 S Broad St, Philadelphia, Pennsylvania. He does not participate in medicare program and thus does not accept medicare assignments. His NPI Number is 1861653495.

Contact Information

	Dr Joseph M Hogan, MD
	1726 S Broad St, Philadelphia, PA 19145-2300
	(215) 334-0700
	(215) 463-4223

Physician's Profile

Full Name	Dr Joseph M Hogan
Gender	Male
Speciality	Internal Medicine - Rheumatology
Location	1726 S Broad St, Philadelphia, Pennsylvania
Accepts Medicare Assignments	Does not participate in Medicare Program. He may not accept medicare assignment.

NPI Data:

NPI Number: 1861653495
Provider Enumeration Date: 06/17/2008
Last Update Date: 06/17/2008

Medical Identifiers

Medical identifiers for Dr Joseph M Hogan such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1861653495	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
207RR0500X	Internal Medicine - Rheumatology	MDOO5859E (Pennsylvania)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr Joseph M Hogan is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Dr Joseph M Hogan, MD 1726 S Broad St, Philadelphia, PA 19145-2300 Ph: () -	Dr Joseph M Hogan, MD 1726 S Broad St, Philadelphia, PA 19145-2300 Ph: (215) 334-0700

News Archive

Webinar features recent updates on meaningful use of certified EHR systems

Community oncologists, practice administrators and clinical staff interested in learning how the American Recovery and Reinvestment Act (ARRA), otherwise known as the stimulus package, can affect health care IT plans for community-based oncology practices are invited to attend a free webinar at 2 p.m. EST (11 a.m. PST) on Friday, Jan. 15, 2010. To register, visit www.MyOncologyServices.com/HIT. Registration is free, but space is limited.

Mallinckrodt receives FDA approval for Fentanyl Transdermal System patch ANDA

Covidien, a leading global provider of healthcare products, today announced that Mallinckrodt Inc., a Covidien company, has received U.S. Food and Drug Administration (FDA) approval of its Abbreviated New Drug Application (ANDA) for its Fentanyl Transdermal System (FTS) patch. Covidien is the largest supplier of controlled pain medications in the United States based on number of prescriptions.

Genetic lab test for Warfarin sensitivity approved by FDA

The U.S. Food and Drug Administration today cleared for marketing a new genetic test that will help physicians assess whether a patient may be especially sensitive to the blood-thinning drug warfarin (Coumadin), which is used to prevent potentially fatal clots in blood vessels.

Mylan settles lawsuits pertaining to Medicaid reimbursements paid to health care providers

Mylan Inc. today announced that it has settled lawsuits brought against it on behalf of the federal government and the state of Texas pertaining to Medicaid reimbursements paid by the federal government and the state of Texas to pharmacists and other health care providers. In exchange for a release of those claims, Mylan has agreed to pay $65 million.

Asuragen obtains license to integrate BRAF V600E mutation sequence into its molecular diagnostic products

Asuragen, Inc., a leader in molecular diagnostics and RNA-based pharmacogenomics services, announced today that it has obtained a non-exclusive license to incorporate the BRAF V600E mutation sequence into Asuragen's molecular diagnostic products. The license was obtained from Johns Hopkins University and includes the use of the BRAF V600E mutation as a component of diagnostic test kits and for use in Asuragen's CLIA laboratory for clinical research and patient testing.

Internal Medicine Doctors in Philadelphia, PA

Philippe Olivier Szapary, MD Rheumatology Medicare: Medicare Enrolled Practice Location: 3400 Civic Center Blvd, East Pavilion, 2nd Floor, Philadelphia, PA 19104 Phone: 215-615-4949
Dr. Jamie L. Garfield, MD Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 3401 N Broad St, Philadelphia, PA 19140 Phone: 215-707-5864 Fax: 215-707-6867
Maria Esther Escorcia De Leon, M.D. Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 3401 N Broad St, Philadelphia, PA 19140 Phone: 215-707-1622 Fax: 215-707-0943
Cherag Daruwala, MD Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 2301 E Allegheny Ave, Suite 190b, Philadelphia, PA 19134 Phone: 215-926-3120 Fax: 215-926-3123
Dr. Robert Burke, M.D. Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 51 N 39th St, Philadelphia, PA 19104 Phone: 215-662-9436 Fax: 215-243-3208
Eva Hassan Alsheik, M.D. Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 219 N Broad St, 5th Floor, Philadelphia, PA 19107 Phone: 215-762-6071
Dr. Jason Thomas Ackrivo, MD Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 3400 Spruce St, Philadelphia, PA 19104 Phone: 215-614-0871

Dr Joseph M Hogan, MD - Internal Medicine in Philadelphia, PA